A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...
Trump administration officials vetoed the FDA's plan to fast-track the review of a psychedelic treatment for severe ...
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...
DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals to develop two agentic AI assistants for ...
AstraZeneca announces update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus: Cambridge, UK Wednesday, February 4, 2026, 16:00 Hrs ...
The Food and Drug Administration (FDA) has warned the public against counterfeit anti-rabies vaccines, which could pose health risks, and reminded them to purchase from establishments licensed by the ...
In January, the FDA released its 2026 Priority Deliverables for its Human Foods Program (HFP), which oversees all food safety ...
The FDA has requested new human factors and pharmacology studies for Anaphylm sublingual film following deficiencies in original NDA packaging data.
The FDA issued a recall after finding rodent and bird contamination at a distribution facility. See which popular food products are affected.
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results